EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Thrombotic Microangiopathy in Childhood Steroid-Resistant Nephrotic Syndrome: Case Series

Dor Fisher, Orly Haskin, Daniel Landau, Yael Borovitz, Choni Rinat, Hadas Alfandary

Nephron · 28.04.2026 · 1-13

DOI: 10.1159/000552049 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephron, online erschienen am 28.04.2026. Verfasst von Dor Fisher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Service, Kaplan Medical Center, Rehovot, Israel, dorfisher@gmail.com. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Thrombotic Microangiopathies. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thrombotic microangiopathy (TMA) with associated nephrotic syndrome is a unique and rare condition that is infrequently described in pediatrics. Case Presentations: Four children with steroid-resistant nephrotic syndrome (SRNS), immune-mediated and of monogenic origin, presented with TMA during late stages of chronic kidney disease. All patients tested negative for Shiga toxin and had normal A Disintegrin-like and Metalloprotease with Thrombospondin type 1 repeats 13 (ADAMTS13) activity. Genetic and functional studies of complement dysregulation were negative. Three of the 4 patients treated with Eculizumab showed good hematologic response but no kidney function recovery. None of the three children who underwent kidney transplantation had recurrent TMA.

Conclusions

TMA may develop in patients with SRNS, manifesting as an unexplained worsening of kidney function, new-onset hypertension, hemolytic anemia, and thrombocytopenia. Eculizumab was effective in improving hemolytic markers without kidney function recovery. TMA did not recur after kidney transplantation in this entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeThrombotic MicroangiopathiesHumansFemaleMaleChildAntibodies, Monoclonal, HumanizedChild, PreschoolDrug Resistance

Stichwörter der Autor:innen

Case reportEculizumabHemolytic uremic syndromeNephrotic syndromeThrombotic microangiopathy

Substanzen

Antibodies, Monoclonal, Humanizedeculizumab

Autor:innen und Institutionen

  • Pediatric Nephrology Service, Kaplan Medical Center, Rehovot, Israel, dorfisher@gmail.com.
  • Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.

Zitieren

APA

Fisher, D., Haskin, O., Landau, D., Borovitz, Y., Rinat, C., & Alfandary, H. (2026). Thrombotic Microangiopathy in Childhood Steroid-Resistant Nephrotic Syndrome: Case Series. Nephron, 1-13. https://doi.org/10.1159/000552049

Vancouver

Fisher D, Haskin O, Landau D, Borovitz Y, Rinat C, Alfandary H. Thrombotic Microangiopathy in Childhood Steroid-Resistant Nephrotic Syndrome: Case Series. Nephron. 2026:1-13. doi:10.1159/000552049

BibTeX
@article{Fisher2026,
  author = {Fisher, Dor and Haskin, Orly and Landau, Daniel and Borovitz, Yael and Rinat, Choni and Alfandary, Hadas},
  title = {Thrombotic Microangiopathy in Childhood Steroid-Resistant Nephrotic Syndrome: Case Series},
  journal = {Nephron},
  year = {2026},
  pages = {1--13},
  doi = {10.1159/000552049}
}
Kostenlos starten →